# Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers

> **NCT04891029** · NA · RECRUITING · sponsor: **McGill University** · enrollment: 5600 (estimated)

## Conditions studied

- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** DOvEEgene test

## Key facts

- **NCT ID:** NCT04891029
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-10
- **Primary completion:** 2025-11
- **Final completion:** 2028-11
- **Target enrollment:** 5600 (ESTIMATED)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891029, "Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04891029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*